Drug profile · INN
dapagliflozin + sitagliptin
SIDAPVIA 10/100
- Patents linked
- 0
- News articles
- 0
Quick answer
dapagliflozin + sitagliptin (SIDAPVIA 10/100) is an FDA-listed pharmaceutical active ingredient. Associated with AstraZeneca.
Key facts
Frequently asked questions
What is dapagliflozin + sitagliptin?
dapagliflozin + sitagliptin (SIDAPVIA 10/100) is an FDA-listed pharmaceutical active ingredient. Associated with AstraZeneca.
What is the brand name for dapagliflozin + sitagliptin?
SIDAPVIA 10/100 is a marketed brand name for dapagliflozin + sitagliptin. Check FDA Drugs@FDA for the current US label holder and prescribing information.